Literature DB >> 25251823

Adaptor regulation of LFA-1 signaling in T lymphocyte migration: Potential druggable targets for immunotherapies?

Navin K Verma1, Dermot Kelleher.   

Abstract

The integrin lymphocyte function associated antigen-1 (LFA-1) plays a key role in leukocyte trafficking and in adaptive immune responses through interactions with adhesive ligands, such as ICAM-1. Specific blockade of these interactions has validated LFA-1 as a therapeutic target in many chronic inflammatory diseases, however LFA-1 antagonists have not been clinically successful due to the development of a general immunosuppression, causing fatal side effects. Growing evidence has now established that LFA-1 mediates an array of intracellular signaling pathways by triggering a number of downstream molecules. In this context, a class of multimodular domain-containing proteins capable of recruiting two or more effector molecules, collectively known as "adaptor proteins," has emerged as important mediators in LFA-1 signal transduction. Here, we provide an overview of the adaptor proteins involved in the intracellular signaling cascades by which LFA-1 regulates T-cell motility and immune responses. The complexity of the LFA-1-associated signaling delineated in this review suggests that it may be an important and challenging focus for future research, enabling the identification of "tunable" targets for the development of immunotherapies.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Adaptor protein; LFA-1; Outside-in signaling; T-cell migration

Mesh:

Substances:

Year:  2014        PMID: 25251823     DOI: 10.1002/eji.201344428

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

1.  Crk adaptor proteins mediate actin-dependent T cell migration and mechanosensing induced by the integrin LFA-1.

Authors:  Nathan H Roy; Joanna L MacKay; Tanner F Robertson; Daniel A Hammer; Janis K Burkhardt
Journal:  Sci Signal       Date:  2018-12-11       Impact factor: 8.192

2.  1,25-dihydroxyvitamin D3 -induced dendritic cells suppress experimental autoimmune encephalomyelitis by increasing proportions of the regulatory lymphocytes and reducing T helper type 1 and type 17 cells.

Authors:  Zhongxiang Xie; Jingtao Chen; Chao Zheng; Jing Wu; Yun Cheng; Shan Zhu; Chenhong Lin; Qingqing Cao; Jie Zhu; Tao Jin
Journal:  Immunology       Date:  2017-07-10       Impact factor: 7.397

Review 3.  Novel Therapies in Development for Diabetic Macular Edema.

Authors:  Aniruddha Agarwal; Rubbia Afridi; Muhammad Hassan; Mohammad Ali Sadiq; Yasir J Sepah; Diana V Do; Quan Dong Nguyen
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

4.  Lymphocyte integrin expression differences between SIRS and sepsis patients.

Authors:  D S Heffernan; S F Monaghan; Alfred Ayala
Journal:  Ir J Med Sci       Date:  2016-10-31       Impact factor: 1.568

5.  Adoptive Transfer of Phosphoantigen-Specific γδ T Cell Subset Attenuates Mycobacterium tuberculosis Infection in Nonhuman Primates.

Authors:  Arwa Qaqish; Dan Huang; Crystal Y Chen; Zhuoran Zhang; Richard Wang; Shengpu Li; Enzhuoa Yang; Yang Lu; Michelle H Larsen; William R Jacobs; Lixia Qian; James Frencher; Ling Shen; Zheng W Chen
Journal:  J Immunol       Date:  2017-05-19       Impact factor: 5.422

6.  Stromal cell-derived DEL-1 inhibits Tfh cell activation and inflammatory arthritis.

Authors:  Hui Wang; Xiaofei Li; Tetsuhiro Kajikawa; Jieun Shin; Jong-Hyung Lim; Ioannis Kourtzelis; Kosuke Nagai; Jonathan M Korostoff; Sylvia Grossklaus; Ronald Naumann; Triantafyllos Chavakis; George Hajishengallis
Journal:  J Clin Invest       Date:  2021-10-01       Impact factor: 14.808

7.  Endothelial Cells Require CD98 for Efficient Angiogenesis-Brief Report.

Authors:  Zhongji Liao; Joseph M Cantor
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-09-29       Impact factor: 8.311

8.  NDRG2 Expression Decreases Tumor-Induced Osteoclast Differentiation by Down-regulating ICAM1 in Breast Cancer Cells.

Authors:  Bomi Kim; Sorim Nam; Ji Hyun Lim; Jong-Seok Lim
Journal:  Biomol Ther (Seoul)       Date:  2016-01-01       Impact factor: 4.634

Review 9.  LFA-1/ICAM-1 Interaction as a Therapeutic Target in Dry Eye Disease.

Authors:  Stephen C Pflugfelder; Michael Stern; Steven Zhang; Amir Shojaei
Journal:  J Ocul Pharmacol Ther       Date:  2016-12-01       Impact factor: 2.671

10.  G-CSF inhibits LFA-1-mediated CD4+ T cell functions by inhibiting Lck and ZAP-70.

Authors:  Shasha Zhao; Zhenyang Gu; Li Wang; Lixun Guan; Feiyan Wang; Nan Yang; Lan Luo; Zhe Gao; Yingwei Song; Lili Wang; Daihong Liu; Chunji Gao
Journal:  Oncotarget       Date:  2017-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.